Trial Profile
Phase I Trial of Zileuton CR in Children and Adults With Sickle Cell Disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Jul 2014
Price :
$35
*
At a glance
- Drugs Zileuton (Primary)
- Indications Sickle cell anaemia
- Focus Adverse reactions; Pharmacokinetics
- 17 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 21 Mar 2014 New trial record